| Dr Carly Paoli, PHARMD | |
|
7560 Topanga Canyon Blvd, Canoga Park, CA 91303-1213 | |
| (818) 340-4031 | |
| Not Available |
| Full Name | Dr Carly Paoli |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7560 Topanga Canyon Blvd, Canoga Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255601878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 63406 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carly Paoli, PHARMD 7560 Topanga Canyon Blvd, Canoga Park, CA 91303-1213 Ph: () - | Dr Carly Paoli, PHARMD 7560 Topanga Canyon Blvd, Canoga Park, CA 91303-1213 Ph: (818) 340-4031 |
News Archive
Patients with strokes, brain tumors and spinal cord injuries are at high risk for life-threatening blood clots, but many do not receive preventive therapy, Loyola University Health System researchers report.
The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research.
A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence, according to a study published in the April 18, 2012 issue of the Journal of the American Medical Association.
The University of Michigan Health System is teaming up with one of India's top academic medical programs to collaborate on trauma care research and to foster exchanges of medical personnel and ideas.
› Verified 3 days ago
Jennifer Hong, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20839 Roscoe Blvd, Canoga Park, CA 91306 Phone: 818-701-8911 Fax: 818-701-8916 | |
Mrs. Jina Kang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7560 Topanga Canyon Blvd, Canoga Park, CA 91303 Phone: 818-340-4031 | |
Dr. Ryan Rene Basa, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6700 Topanga Canyon Blvd, Canoga Park, CA 91303 Phone: 818-746-9923 | |
Steven James Markis, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7560 Topanga Canyon Blvd, Canoga Park, CA 91303 Phone: 818-340-4031 | |
Christine Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7560 Topanga Canyon Blvd, Canoga Park, CA 91303 Phone: 818-340-4031 Fax: 818-340-4859 | |
Gary Lowe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 8220 Remmet Ave, Canoga Park, CA 91304 Phone: 818-746-9800 | |
Prof. Astine Petrosyan Iv, PHAMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6700 Topanga Canyon Blvd, T2143, Canoga Park, CA 91303 Phone: 818-383-6166 |